Influence of darolutamide on cabazitaxel systemic exposure.

Buck, S; Guchelaar, NAD; De Bruijn, P; Moghaddam-Helmantel, IMG; De Hoop, EO; Westgeest, HM; Hamberg, P; Mathijssen-Van Stein, D; Lolkema, MP; Koolen, SLW; De Wit, R; Mathijssen, RHJ

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):